Weight Loss & Obesity Management Market Sales & Size to 2034

Weight Loss and Obesity Management Market Overview from 2024 to 2034

The weight loss and obesity management market is projected to rise at a CAGR of 12.8% during the projected period. The market value is projected to increase from US$ 14,511 million in 2024 to US$ 48,396 million by 2034.

Attributes	Details
Weight Loss and Obesity Management Market Size, 2024	US$ 14,511 million
Projected Market Size, 2034	US$ 48,396 million
Value-based CAGR (2024 to 2034)	12.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Weight Loss and Obesity Management Market Size, Analysis, and Insights

The weight loss and obesity management market has been experiencing a surge in demand and the trend is expected to continue in the foreseeable future.
The increasing prevalence of obesity and related health conditions, such as diabetes, heart disease, and hypertension, has fueled the demand for weight loss and obesity management solutions.
As people become more educated about the link between obesity and chronic diseases, they are increasingly seeking out weight loss solutions as a way to improve their overall health and reduce their risk of developing serious health issues.
Changing lifestyle patterns have played a role in driving demand for weight loss and obesity management solutions. As people lead increasingly busy and sedentary lives, they are more likely to experience weight gain and related health issues.

Key Opportunities for Weight Loss and Obesity Management Market Players

The market is a rapidly growing sector, driven by increasing awareness about the risks associated with obesity and the desire for a healthier lifestyle.

The rise of personalized weight loss and obesity management programs is expected to create significant opportunities in the industry.
With the advent of technology, it is now possible to track individual health metrics and create customized programs based on these metrics. Individuals receive tailored recommendations that are specific to their unique needs, increasing the chances of successful weight loss and management.
The growing trend toward non-surgical and minimally invasive procedures for weight loss and obesity management is expected to propel growth in the market.
The rise in the global healthcare industry is also driving the weight loss and obesity management market forward.
Healthcare providers are increasingly recognizing the importance of weight loss and obesity management in preventing chronic diseases such as diabetes and heart disease. Therefore, there is a growing demand for weight loss and obesity management products and services in the healthcare industry.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the Weight Loss and Obesity Management Market

The weight loss and obesity management market is experiencing significant growth. However, there are several market challenges that companies in the industry need to address to remain competitive and succeed.

The saturation of the market with weight loss products and services is expected to hamper growth in the coming years.
Consumers have a wide range of options to choose from, including diet plans, supplements, fitness programs, and surgery. With so many choices available, it can be difficult for companies to differentiate themselves and attract customers.
The high cost of several weight loss products and services acts as a restraint. The market is dominated by premium brands that charge premium prices, making it difficult for lower-priced alternatives to gain traction. Additionally, insurance coverage for weight loss treatments is often limited, which can make it hard for consumers to afford the care they need.
Regulatory challenges are also a concern in the weight loss and obesity management market. Many weight loss products and treatments are considered medical devices by regulatory authorities, which means they must undergo rigorous testing and approval processes before they can be sold to consumers.

Category-wise Insights

The Drugs Segment Dominates the Market by Products

Attributes	Details
Top Product	Drugs
Market Share in 2024	48.60%

The increasing demand for effective and efficient weight loss solutions is fueling product sales.
The growing prevalence of obesity and related diseases, such as diabetes, cardiovascular diseases, and cancer, is driving the demand for weight loss drugs.
The pharmaceutical industry is investing heavily in research and development activities to develop innovative weight loss drugs with minimal side effects, which is further stimulating the growth of this segment.

The Institution Sales Segment Leads the Market by Distribution Channel

Attributes	Details
Top Distribution Channel	Institution Sales
Market Share in 2024	75.70%

The increasing prevalence of obesity and related disorders drives institutional sales.
The rising awareness about the health risks associated with obesity and the growing demand for personalized weight loss solutions are also contributing to the growth of the institution's sales segment.
Institutions such as hospitals, clinics, and wellness centers offer a wide range of weight loss solutions, including medical therapies, weight loss surgeries, and lifestyle management programs, which are tailored to the individual needs of the patients.

Country-wise insights

Countries	CAGR (2024 to 2034)
China	5.90%
United Kingdom	4.00%
India	6.20%

Rise of eCommerce Platforms and Online Health and Wellness Portals in India

The rise in disposable income of the middle-class population has led to an increase in spending on health and wellness products in India. People are becoming more conscious of their health and are willing to invest in products and services that can help them achieve their fitness goals.
The growing prevalence of obesity in India has led to increased awareness about the importance of weight management.
The rise of eCommerce platforms and online health and wellness portals has made it easier for consumers to access a wide range of weight loss and obesity management products.
The availability of affordable and effective weight loss and obesity management solutions has also played a significant role in driving market growth in India. There are several products and services available in the market that are tailored to the specific needs of Indian consumers. These include Ayurvedic remedies, low-calorie meal replacements, and fitness programs that cater to different age groups and fitness levels.

Rise in Disposable Income and the Growing Middle Class in China

The rise in disposable income and the growing middle class in China have led to an increased focus on health and wellness. As people become more aware of the negative health impacts of obesity and being overweight, they are seeking out products and services that can help them lose weight and maintain a healthy lifestyle.
The prevalence of obesity in China has been steadily increasing over the past few decades.
The Chinese government has launched several initiatives to combat obesity and promote healthy lifestyles. The initiatives include the implementation of a national fitness program and the promotion of healthy eating habits. As a result, there has been an increased awareness of the importance of weight loss and healthy living among the Chinese population.

Increasing Government Initiatives Addressing the Obesity Epidemic in the United Kingdom

The increasing awareness and concern around the negative health impacts of being overweight or obese in the United Kingdom is driving growth in the market. With the prevalence of obesity and associated health problems such as diabetes, heart disease, and stroke, many individuals are seeking ways to manage their weight and improve their overall health.
The United Kingdom government has been taking steps to address the obesity epidemic, including launching campaigns to promote healthy eating and physical activity, implementing sugar taxes, and investing in weight management programs.
The government initiatives have helped to raise awareness and encourage individuals to take action to manage their weight, which is expected to drive market growth in the region.

Competitive Landscape

The market is highly competitive, with numerous players operating in the industry. Companies offer a range of products and services, including weight loss programs, meal replacements, supplements, and fitness equipment. The market is also characterized by the emergence of several start-ups and niche players who are offering innovative solutions to address the growing demand for weight loss and obesity management products and services.

Recent Developments

In 2021, Phase IIIa study concluded that semaglutide, a weight-loss medication developed by Novo Nordisk, has the potential to improve the physical function and overall well-being of individuals who are obese.
In 2023, a strategic partnership has been announced between PRISTYN CARE, a healthcare service provider, and Allurion, a company that specializes in developing medical devices for weight loss. Through this partnership, the two companies aim to offer a comprehensive platform for obesity care and weight-loss solutions.
In 2022, Amgen Inc. recently shared Phase 1 findings about AMG 133, a new bispecific molecule designed as a glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist. The study aimed to assess the impact of this first-in-human molecule on individuals with obesity but without diabetes, with a focus on evaluating its safety, tolerability, pharmacokinetic, and pharmacodynamics effects.

Key Market Players

Atkins Nutritionals, Inc.
Ethicon US, LLC
Herbalife Ltd.
Nutrisystem, Inc.
Weight Watchers International, Inc.
Jenny Craig, Inc.
Apollo Endosurgery, Inc.
Brunswick Corporation
Covidien plc

Key Coverage in the Weight Loss and Obesity Management Market Report

Obesity Prevention Strategies Analysis
Weight Loss and Obesity Management Market Assessment
Obesity Treatment Industry Outlook
Obesity Management Pricing Analysis
Demand for Bariatric Surgery Devices Overlook

Key Market Segmentation

By Product Type:

Devices
- Liposuction Devices
- Laser-assisted Liposuction Devices
- Radio Frequency-assisted Liposuction Devices
- Ultrasound-assisted Liposuction Devices
- Bariatric Stapling Devices
- Gastric Bands
- Gastric Balloon Systems
- Gastric Emptying Systems
- Gastric Electrical Stimulation Systems
Drugs
- GLP-1 Receptor Agonists
- Lipase Inhibitors
- Serotonin Receptor Agonists
- Combination Drugs
- Others

By Distribution Channel:

Institutional Sales
- Hospitals
- Weight Loss Clinics
- Ambulatory Surgery Centers
Retail Sales
- Retail Pharmacies
- Drug Stores
- Online Sales

By Region:

North America
Latin America
East Asia
South Asia
Europe
Oceania
MEA

Frequently Asked Questions

How Big is the Weight Loss and Obesity Management Market in 2024?

The weight loss and obesity management market is estimated to be valued at around US$ 14,511 million in 2024.

What is China’s Market Outlook?

The market in China is expected to progress at a CAGR of 5.90% over the forecast period.

Which Product Segment Contributes More to the Weight Loss and Obesity Management Market?

Within the products, the drugs segment is expected to register a 48.60% market share in 2024.

What is the India's Market Outlook?

The market in India is projected to expand at a 6.20% CAGR from 2024 to 2034.

What is the Projected Value of the Market by 2034?

The market is set to reach a valuation of around US$ 48,396 million by 2034.

What Was the Historical CAGR for the Market?

The demand for weight loss and obesity management increased at a 23.9% CAGR from 2019 to 2023.

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2024 to 2034
5.3.1. Devices
5.3.1.1. Liposuction Devices
5.3.1.2. Laser-assisted Liposuction Devices
5.3.1.3. Radio Frequency-assisted Liposuction Devices
5.3.1.4. Ultrasound-assisted Liposuction Devices
5.3.1.5. Bariatric Stapling Devices
5.3.1.6. Gastric Bands
5.3.1.7. Gastric Balloon Systems
5.3.1.8. Gastric Emptying Systems
5.3.1.9. Gastric Electrical Stimulation Systems
5.3.2. Drugs
5.3.2.1. GLP-1 Receptor Agonists
5.3.2.2. Lipase Inhibitors
5.3.2.3. Serotonin Receptor Agonists
5.3.2.4. Combination Drugs
5.3.2.5. Others
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034
6.3.1. Institutional Sales
6.3.1.1. Hospitals
6.3.1.2. Weight Loss Clinics
6.3.1.3. Ambulatory Surgery Centres
6.3.2. Retail Sales
6.3.2.1. Retail Pharmacies
6.3.2.2. Drug Stores
6.3.2.3. Online Sales
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By Distribution Channel
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Distribution Channel
8.4. Key Takeaways
9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Distribution Channel
9.4. Key Takeaways
10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Product Type
10.2.3. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Distribution Channel
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Product Type
11.2.3. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Distribution Channel
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Product Type
12.2.3. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Distribution Channel
12.4. Key Takeaways
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Distribution Channel
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product Type
14.2.3. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Distribution Channel
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2023
15.1.2.1. By Product Type
15.1.2.2. By Distribution Channel
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2023
15.2.2.1. By Product Type
15.2.2.2. By Distribution Channel
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2023
15.3.2.1. By Product Type
15.3.2.2. By Distribution Channel
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2023
15.4.2.1. By Product Type
15.4.2.2. By Distribution Channel
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2023
15.5.2.1. By Product Type
15.5.2.2. By Distribution Channel
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2023
15.6.2.1. By Product Type
15.6.2.2. By Distribution Channel
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2023
15.7.2.1. By Product Type
15.7.2.2. By Distribution Channel
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2023
15.8.2.1. By Product Type
15.8.2.2. By Distribution Channel
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2023
15.9.2.1. By Product Type
15.9.2.2. By Distribution Channel
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2023
15.10.2.1. By Product Type
15.10.2.2. By Distribution Channel
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2023
15.11.2.1. By Product Type
15.11.2.2. By Distribution Channel
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2023
15.12.2.1. By Product Type
15.12.2.2. By Distribution Channel
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2023
15.13.2.1. By Product Type
15.13.2.2. By Distribution Channel
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2023
15.14.2.1. By Product Type
15.14.2.2. By Distribution Channel
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2023
15.15.2.1. By Product Type
15.15.2.2. By Distribution Channel
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2023
15.16.2.1. By Product Type
15.16.2.2. By Distribution Channel
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2023
15.17.2.1. By Product Type
15.17.2.2. By Distribution Channel
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2023
15.18.2.1. By Product Type
15.18.2.2. By Distribution Channel
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2023
15.19.2.1. By Product Type
15.19.2.2. By Distribution Channel
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2023
15.20.2.1. By Product Type
15.20.2.2. By Distribution Channel
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2023
15.21.2.1. By Product Type
15.21.2.2. By Distribution Channel
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2023
15.22.2.1. By Product Type
15.22.2.2. By Distribution Channel
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2023
15.23.2.1. By Product Type
15.23.2.2. By Distribution Channel
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By Distribution Channel
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. GlaxoSmithKline plc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Allergan Plc
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Johnson & Johnson Services, Inc.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Vivus Inc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Eisai Co., Ltd.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. ReShape Lifesciences, Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Aspire Bariatrics
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Allurion Technologies Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Cheplapharm Arzneimittel GmbH
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Beijing Noble Laser Technology Co., Ltd.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Weight Loss and Obesity Management Market

Weight Loss and Obesity Management Market Analysis by Internation Sales and Retail Sales Distribution Channels for 2024 to 2034